Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Altimmune Is Crashing Today


Altimmune (NASDAQ: ALT) was plummeting in late trading on Wednesday, with the shares in free fall by nearly 40%. That was no surprise given the company's revelation the previous afternoon.

Just after market close on Tuesday, Altimmune officially threw in the towel on the development of its COVID-19 vaccine, AdCOVID. It's also halting enrollment on a phase 1/2 clinical trial of its T-COVID drug, which had been under way.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
ALT
Share

Comments